'New' sales double at Craneware

'New' sales double at Craneware

Craneware's (CRW) newer Pharmacy ChargeLink solution is clearly popular with hospitals in the US. In the year to June 2018, it overtook the group's older revenue management system Chargemaster to become its best-selling product. This helped double 'new' sales to $71.3m (£55.6m), defined as new contracts with existing or new customers. Thus, Craneware was rewarded with a double-digit share price rise on results day. 

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now